Citation Impact
Citing Papers
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Differential trigeminovascular nociceptive responses in the thalamus in the familial hemiplegic migraine 1 knock-in mouse: A Fos protein study
2013
ZOLMITRIPTAN PROVIDES EFFECTIVE MIGRAINE RELIEF IN ADOLESCENTS
2000
Migraine Frequency and Intensity: Relationship With Disability and Psychological Factors
2003
Antiepileptic drugs: indications other than epilepsy
2004
CGRP and migraine: neurogenic inflammation revisited
2005
The pharmacology of headache
2000
Ketorolac versus meperidine and hydroxyzine in the treatment of acute migraine headache: A randomized, prospective, double-blind trial
1992
Descending control of pain
2002 Standout
Substance P receptor antagonists in the therapy of migraine
2001
Selective spider toxins reveal a role for the Nav1.1 channel in mechanical pain
2016 StandoutNatureNobel
Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators
2012
Familial and Sporadic Hemiplegic Migraine: Diagnosis and Treatment
2012
Newer antiepileptic drugs: Possible uses in the treatment of neuropathic pain and migraine
2003
Animal models of migraine: looking at the component parts of a complex disorder
2006
Clinical approaches to treatment of Internet addiction
2014 Standout
Stratified Care vs Step Care Strategies for Migraine
2000
Triptans in Migraine
2000
Sinus Headache: A Neurology, Otolaryngology, Allergy, and Primary Care Consensus on Diagnosis and Treatment
2005
The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept
2007 Standout
The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials
2008 Standout
Advances in the Pharmacotherapy of Migraine
1999
Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine
2004 Standout
Antiepileptic drugs in migraine: from clinical aspects to cellular mechanisms
2007
The anti‐migraine 5‐HT1B/1D agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea‐pigs
2001
Overview of pediatric headache
2004
Modulation of GABAA receptor desensitization uncouples sleep onset and maintenance in Drosophila
2008 StandoutNobel
Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II
2001 Standout
Valproate-Induced Insulin Resistance and Obesity in Children
2009
Migraine — Current Understanding and Treatment
2002 Standout
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Botulinum Toxin Type A for the Prophylaxis of Chronic Daily Headache: Subgroup Analysis of Patients Not Receiving Other Prophylactic Medications: A Randomized Double‐Blind, Placebo‐Controlled Study
2005
Ketorolac as a rapid and effective treatment of migraine headache: Evaluations by patients
1993
EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force
2009
Current practice and future directions in the prevention and acute management of migraine
2010
Drug Therapy of Migraine
1993
Very Small Cerebellar Infarcts: Integration of Recent Insights into a Functional Topographic Classification
2013 Standout
Donitriptan, but not sumatriptan, inhibits capsaicin‐induced canine external carotid vasodilatation via 5‐HT1Brather than 5‐HT1Dreceptors
2006
Indoles as therapeutics of interest in medicinal chemistry: Bird's eye view
2017 Standout
The 2012 AHS/AAN Guidelines for Prevention of Episodic Migraine: A Summary and Comparison With Other Recent Clinical Practice Guidelines
2012 Standout
A meta-analysis of the placebo response in acute migraine and how this response may be influenced by some of the characteristics of clinical trials
2006
Transient Receptor Potential Cation Channels in Disease
2007 Standout
Should We Advise Patients to Treat Migraine Attacks Early: Methodologic Issues
2005
The Global Burden of Headache: A Documentation of Headache Prevalence and Disability Worldwide
2007 Standout
Migraine and Stroke
2012
RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH
2012 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
Therapeutic implications of central and peripheral neurologic mechanisms in migraine
2003
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
2010 Standout
The Hitchhiker’s Guide to Flow Chemistry
2017 Standout
Marine Indole Alkaloids: Potential New Drug Leads for the Control of Depression and Anxiety
2010 Standout
Non-epilepsy uses of antiepilepsy drugs.
2006
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Acute Migraine Therapy: Do Doctors Understand What Patients With Migraine Want From Therapy?
1999
Migraine headache is present in the aura phase
2012
Prospective Analysis of Factors Related to Migraine Attacks: The PAMINA Study
2007 Standout
The Importance of Placebo in Headache Research
2008
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Clinical Practice Guideline (Update): Adult Sinusitis
2015 Standout
Recent Advances in the Understanding and Treatment of Migraine
1993
Patterns of health care utilization for migraine in England and in the United States
2003 Standout
Clinical practice guideline: Adult sinusitis
2007 Standout
Triptans (Serotonin, 5-HT1B/1D Agonists) in Migraine: Detailed Results and Methods of A Meta-Analysis of 53 Trials
2002
Guideline for primary care management of headache in adults.
2015 Standout
Guidelines for the diagnosis and management of migraine in clinical practice. Canadian Headache Society.
1997 Standout
Works of J. A. Klapper being referenced
Standards of care for treating headache in primary care practice
1997
Triptans in the Treatment of Basilar Migraine and Migraine With Prolonged Aura
2001
Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patients with acute migraine
2001
Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine
1997
Ketorolac Versus DHE and Metoclopramide in the Treatment of Migraine Headaches
1991
Benefits of Treating Highly Disabled Migraine Patients with Zolmitriptan while Pain is Mild
2004
Divalproex Sodium in Migraine Prophylaxis
1997
Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patients with acute migraine.
2001